Cargando…
Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota
Gut microbiota-related metabolites are potential clinical biomarkers for cardiovascular disease (CVD). Circulating succinate, a metabolite produced by both microbiota and the host, is increased in hypertension, ischemic heart disease, and type 2 diabetes. We aimed to analyze systemic levels of succi...
Autores principales: | Serena, Carolina, Ceperuelo-Mallafré, Victoria, Keiran, Noelia, Queipo-Ortuño, Maria Isabel, Bernal, Rosa, Gomez-Huelgas, Ricardo, Urpi-Sarda, Mireia, Sabater, Mónica, Pérez-Brocal, Vicente, Andrés-Lacueva, Cristina, Moya, Andres, Tinahones, Francisco J, Fernández-Real, Jose Manuel, Vendrell, Joan, Fernández-Veledo, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018807/ https://www.ncbi.nlm.nih.gov/pubmed/29434314 http://dx.doi.org/10.1038/s41396-018-0068-2 |
Ejemplares similares
-
Metabolomic insights into the intricate gut microbial–host interaction in the development of obesity and type 2 diabetes
por: Palau-Rodriguez, Magali, et al.
Publicado: (2015) -
Erratum. Preoperative Circulating Succinate Levels as a Biomarker for Diabetes Remission After Bariatric Surgery. Diabetes Care 2019;42:1956–1965
por: Ceperuelo-Mallafré, Victoria, et al.
Publicado: (2019) -
Impaired Succinate Response to a Mixed Meal in Obesity and Type 2 Diabetes Is Normalized After Metabolic Surgery
por: Astiarraga, Brenno, et al.
Publicado: (2020) -
Changes in glucagon‐like peptide 1 and 2 levels in people with obesity after a diet‐induced weight‐loss intervention are related to a specific microbiota signature: A prospective cohort study
por: Rodríguez‐Peña, M‐Mar, et al.
Publicado: (2021) -
FABP4 Dynamics in Obesity: Discrepancies in Adipose Tissue and Liver Expression Regarding Circulating Plasma Levels
por: Queipo-Ortuño, María Isabel, et al.
Publicado: (2012)